Cannabis
Van Santen Family Trust: Early Warning Report in Accordance with Multilateral Instrument 62-104 and National Instrument 62-103
This press release is issued pursuant to Multilateral instrument 62-104 – Take-Over Bids and issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting issues.
Vancouver, British Columbia–(Newsfile Corp. – November 11, 2020) – The Van Santen Family Trust announces that on November 6, 2020 it acquired 2,500 Convertible Debentures (the “Debentures”) of AgriCann Solutions Inc. (the “Issuer”). The Debentures were issued pursuant to a convertible debenture private placement financing and are convertible for one year into 1,000,000 common shares and 500,000 warrants of the Issuer without further payment. The Van Santen Family Trust currently holds or controls approximately 23.32% of the issued and outstanding shares of the Issuer, which would increase to 28.28% upon conversion of the principal amount of the entire issue of the Debentures, and 29.59% upon exercise of all issued warrants. The Debentures were acquired for investment purposes, which investment in the issuer will be evaluated and increased or decreased from time to time at the Van Santen Family Trust’s discretion.
A report respecting this acquisition will be electronically filed with the securities Commissions in British Columbia and Alberta and will be available for viewing through the Internet at the Canadian System for Electronic Analysis and Retrieval (SEDAR) at www.sedar.com.
(signed) “Robert van Santen”
Robert van Santen
Authorised Signatory
Van Santen Family Trust
For further information, please contact:
Robert van Santen, CA, CPA, CMT
Telephone: +1.604.608.1999
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68002
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
SCHWAZZE3 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth